1-[(4-CHLOROPHENYL)METHYL]-3-ISOPROYL-2,1,3-BENZOTHIADIAZIN-4-ONE-2,2-DIOXIDE
Compound with spectra: 1 NMR
![1-[(4-CHLOROPHENYL)METHYL]-3-ISOPROYL-2,1,3-BENZOTHIADIAZIN-4-ONE-2,2-DIOXIDE](/api/compound/Hy4D9ii7Z1K.png?ph=true&h=300&w=458 "1-[(4-CHLOROPHENYL)METHYL]-3-ISOPROYL-2,1,3-BENZOTHIADIAZIN-4-ONE-2,2-DIOXIDE")
| SpectraBase Compound ID | Hy4D9ii7Z1K |
|---|---|
| InChI | InChI=1S/C17H17ClN2O3S/c1-12(2)20-17(21)15-5-3-4-6-16(15)19(24(20,22)23)11-13-7-9-14(18)10-8-13/h3-10,12H,11H2,1-2H3 |
| InChIKey | CFUSEGFJDBPZTR-UHFFFAOYSA-N |
| Mol Weight | 364.85 g/mol |
| Molecular Formula | C17H17ClN2O3S |
| Exact Mass | 364.064841 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
1-BENZYL-3-ISOPROPYL-1H-2,1,3-BENZOTHIADIAZIN-(4)-3H-ONE 2,2-DIOXIDE
1-[(4-CHLOROPHENYL)METHYL]-3-PROPYL-2,1,3-BENZOTHIADIAZIN-4-ONE-2,2-DIOXIDE
1-(PHENYLBUTHYL)-3-BENZYL-2,1,3-BENZOTHIADIAZIN-4-ONE-2,2-DIOXIDE
1H-2,1,3-Benzothiadiazin-4(3H)-one, 8-methoxy-1-methyl-3-(1-methylethyl)-, 2,2-dioxide
1-[(3,4-DICHLOROPHENYL)MEHYL]-4-(CYCLOHEXYLMETHYLOXY)-2,1,3-BENZOTHIADIAZIN-2,2-DIOXIDE
1-[(3,4-DICHLOROPHENYL)MEHYL]-4-(ISOBUTYLOXY)-2,1,3-BENZOTHIADIAZIN-2,2-DIOXIDE
2,10-dihydro-10-(p-fluorobenzyl)imidazo[2,1-b]quinazolin-5(3H) one, methanesulfonate(1:1)
4-[(1-(3-fluorobenzyl)-2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)methyl]-N-(3-methoxypropyl)benzamide
10-(4-Fluorobenzyl)-2,10-dihydroimidazo-(2,1-b)quinazolin-5(3H)-one HCl
4(1H)-quinolinone, 1-[(3-fluorophenyl)methyl]-6-methoxy-3-(4-methylbenzoyl)-
| Title | Journal or Book | Year |
|---|---|---|
| Benzothiadiazine dioxides (BTD) derivatives as non-nucleoside human cytomegalovirus (HCMV) inhibitors. study of structural requirements for biological activity☆ | Bioorganic & Medicinal Chemistry | 2003 |